Search by Drug Name or NDC
NDC 71993-0307-60 Orphenadrine Citrate, Aspirin and Caffeine 770; 60; 50 mg/1; mg/1; mg/1 Details
Orphenadrine Citrate, Aspirin and Caffeine 770; 60; 50 mg/1; mg/1; mg/1
Orphenadrine Citrate, Aspirin and Caffeine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Atland Pharmaceuticals, LLC. The primary component is ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE.
Product Information
| NDC | 71993-0307 |
|---|---|
| Product ID | 71993-307_fe86c929-95df-1849-e053-6294a90a897d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Orphenadrine Citrate, Aspirin and Caffeine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Orphenadrine Citrate, Aspirin and Caffeine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 770; 60; 50 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE |
| Labeler Name | Atland Pharmaceuticals, LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Centrally-mediated Muscle Relaxation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prost |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075141 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71993-0307-60 (71993030760)
| NDC Package Code | 71993-307-60 |
|---|---|
| Billing NDC | 71993030760 |
| Package | 60 TABLET in 1 BOTTLE, PLASTIC (71993-307-60) |
| Marketing Start Date | 2023-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |